Tauzin, Billy Rep

=see medicare negot drug pricefuries pjt? poster for rev door?alec alum=ghreat recession wendy gramm enron (robert bradley)Conflicts of Interest within Auditors: In April, 2000, SEC chairman Arthur Levitt proposed that auditing firms not be allowed to consult with the same companies that they were auditing, since wearing both hats puts auditing firms in a position where they have an interest in not rocking the boat. Levitt was not speculating about problems that might happen as a result of such conflicts. Already, he had ample evidence that the practice of issuing “managed earnings” had “absolutely exploded.” And Arthur Anderson had already been fined $7 million for its role in advising Waste Management Inc., which paid $457 in penalties for overstating its earnings between 1993 and 1997. To defeat the proposal, Anderson was joined by two other major accounting firms, KPMG and Deloitte & Touche, in an all-out lobbying campaign that included nearly $23 million in campaign contributions to both parties. One well-positioned Congressman, Billy Tauzin of Louisiana, had received $300,000 from the accounting industry over the prior decade. Seven lobbying firms worked on Capitol Hill to kill the proposal. The committee that oversees the SEC put pressure on the agency to abandon the proposal. This despite multiple convictions of Arthur Anderson and other firms.  gangs of america<div style="background-color: rgb(255, 255, 255);">=</div><div style="background-color: rgb(255, 255, 255);">
</div><div style="background-color: rgb(255, 255, 255);">pat morrissey esq staffer ag west va</div><div style=""><div style="background-color: rgb(255, 255, 255);">
</div><div style="background-color: rgb(255, 255, 255);">https://en.wikipedia.org/wiki/Medicare_Prescription_Drug,Improvement,and_Modernization_Act</div><div style="background-color: rgb(255, 255, 255);">
</div><div style="background-color: rgb(255, 255, 255);">hastert? dubya tozzi?</div><div style="background-color: rgb(255, 255, 255);">
</div><div style="background-color: rgb(255, 255, 255);">wiki</div><div style="background-color: rgb(255, 255, 255);">
</div><div style="">For several minutes, the vote total was stuck at 58-39, until Senators <a href="https://en.wikipedia.org/wiki/Lindsey_Graham" title="Lindsey Graham" style="text-decoration-line: none; font-weight: bold; outline: none; background: none;">Lindsey Graham</a> (R-SC), <a href="https://en.wikipedia.org/wiki/Trent_Lott" title="Trent Lott" style="text-decoration-line: none; font-weight: bold; outline: none; background: none;">Trent Lott</a> (R-MS), and <a href="https://en.wikipedia.org/wiki/Ron_Wyden" title="Ron Wyden" style="text-decoration-line: none; font-weight: bold; outline: none; background: none;">Ron Wyden</a> (D-OR) voted in quick succession in favor to pass the vote 61-39.<a href="https://en.wikipedia.org/wiki/Medicare_Prescription_Drug,Improvement,and_Modernization_Act#cite_note-16" style="text-decoration-line: none; font-weight: bold; outline: none; background: none;">[16]</a> The bill itself was finally passed 54-44 on November 25, 2003, and was signed into law by the President on December 8.<a href="https://en.wikipedia.org/wiki/Medicare_Prescription_Drug,Improvement,and_Modernization_Act#cite_note-17" style="text-decoration-line: none; font-weight: bold; outline: none; background: none;">[17]</a><h2 linux="Linux" libertine="Libertine" georgia="Georgia" times="Times" serif="serif" line-height="line-height" background-color="background-color" rgb="rgb" style="background-color: rgb(255, 255, 255); margin: 1em 0px 0.25em; padding: 0px; overflow: hidden; border-bottom: 1px solid rgb(162, 169, 177); font-weight: normal;">Costs[</h2>Initially, the net cost of the program was projected at $400 billion for the ten-year period between 2004 and 2013. Administration official <a href="https://en.wikipedia.org/wiki/Thomas_A.Scully" title="Thomas A. Scully" style="text-decoration-line: none; font-weight: bold; outline: none; background: none;">Thomas Scully</a> instructed analyst Richard Foster not to tell Congress of Foster's finding that the cost would actually be over $500 billion. One month after passage, the administration estimated that the net cost of the program over the period between 2006 (the first year the program started paying benefits) and 2015 would be $534 billion.<a href="https://en.wikipedia.org/wiki/Medicare_Prescription_Drug,Improvement,and_Modernization_Act#cite_note-18" style="text-decoration-line: none; font-weight: bold; outline: none; background: none;">[18]</a> As of February 2009, the projected net cost of the program over the 2006 to 2015 period was $549.2 billion.<a href="https://en.wikipedia.org/wiki/Medicare_Prescription_Drug,Improvement,and_Modernization_Act#cite_note-19" style="text-decoration-line: none; font-weight: bold; outline: none; background: none;">[19]</a><h2 linux="Linux" libertine="Libertine" georgia="Georgia" times="Times" serif="serif" line-height="line-height" background-color="background-color" rgb="rgb" style="background-color: rgb(255, 255, 255); margin: 1em 0px 0.25em; padding: 0px; overflow: hidden; border-bottom: 1px solid rgb(162, 169, 177); font-weight: normal;">Bar to negotiation of prescription drug prices[</h2>Since the enactment of Medicare Prescription Drug, Improvement, and Modernization Act in 2003, only <a href="https://en.wikipedia.org/wiki/Insurance" title="Insurance" style="text-decoration-line: none; font-weight: bold; outline: none; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">insurance</a> companies administering Medicare prescription drug program, not Medicare, have the legal right to negotiate drug prices directly from drug manufacturers. The Medicare Prescription Drug Act expressly prohibited Medicare from negotiating bulk prescription drug prices.<a href="https://en.wikipedia.org/wiki/Medicare_Prescription_Drug,Improvement,and_Modernization_Act#cite_note-20" style="background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none; outline: none;">[</a><a href="https://en.wikipedia.org/wiki/Medicare_Prescription_Drug,Improvement,and_Modernization_Act#cite_note-20" style="background: none; text-decoration-line: none; font-weight: bold; outline: none;">20]</a> The "donut hole" provision of the <a href="https://en.wikipedia.org/wiki/Patient_Protection_and_Affordable_Care_Act" class="mw-redirect" title="Patient Protection and Affordable Care Act" style="text-decoration-line: none; font-weight: bold; outline: none; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Patient Protection and Affordable Care Act</a> was an attempt to correct the issue.<a href="https://en.wikipedia.org/wiki/Medicare_Prescription_Drug,Improvement,_and_Modernization_Act#cite_note-medicare.gov-21" style="text-decoration-line: none; font-weight: bold; outline: none; background: none;">[21]</a></div><div style="background-color: rgb(255, 255, 255);">=</div></div>=bs reason mag<p style="box-sizing: border-box; margin-bottom: 1rem; margin-top: 0px; font-family: itc-slimbach, " times="Times" new="New" roman="Roman" serif="serif" font-size="font-size" px="px" line-height="line-height" rem="rem" color="color" rgb="rgb" background-color="background-color">Cancer took 65 pounds off of me and beat the hell out of me," says Wilbert "Billy" Tauzin, the former congressman from Louisiana's third district. "Now I'm watching patients use medical marijuana products to get through that a lot easier than I did, and I'm thinking, 'Wow, why didn't we have that opportunity 15 years ago?'"<p style="box-sizing: border-box; margin-bottom: 1rem; margin-top: 0px; font-family: itc-slimbach, " times="Times" new="New" roman="Roman" serif="serif" font-size="font-size" px="px" line-height="line-height" rem="rem" color="color" rgb="rgb" background-color="background-color">After serving in Congress from 1980 to 1995 as a Democrat and from 1995 to 2005 as a Republican, Tauzin made his way through the revolving door to PhRMA, the lobbying powerhouse that represents the American pharmaceutical industry. Now 75, Tauzin is living a third—some might say fourth—act as an advocate for marijuana reform with LenitivLabs, the medical cannabis company founded by TV host Montel Williams.<p style="box-sizing: border-box; margin-bottom: 1rem; margin-top: 0px; font-family: itc-slimbach, " times="Times" new="New" roman="Roman" serif="serif" font-size="font-size" px="px" line-height="line-height" rem="rem" color="color" rgb="rgb" background-color="background-color">At this year's Cannabis World Congress and Business Exposition in New York City, Tauzin spoke to Reason's Nick Gillespie about the politics of pot.<p style="box-sizing: border-box; margin-bottom: 1rem; margin-top: 0px; font-family: itc-slimbach, " times="Times" new="New" roman="Roman" serif="serif" font-size="font-size" px="px" line-height="line-height" rem="rem" color="color" rgb="rgb" background-color="background-color">Q: Do all former congressmen have to get cancer before we're going to get medical marijuana or recreational marijuana?<div align="center" class="advertisement freestar-ad-sidebar-container" id="anchor_first" style="box-sizing: border-box; place-content: center; -webkit-box-align: center; align-items: center; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; display: flex; -webkit-box-orient: vertical; -webkit-box-direction: normal; flex-direction: column; -webkit-box-pack: center; text-align: center; border: 0px; margin: 0.5rem auto;"><p style="background-color: rgba(224, 224, 224, 0.2); text-align: left; box-sizing: border-box; margin-bottom: 1rem; margin-top: 0px;" times="Times" new="New" roman="Roman" serif="serif" font-size="font-size" px="px" line-height="line-height" rem="rem" color="color" rgb="rgb" background-color="background-color">A: God, I hope not. I told the audience today that if Congress did a secret ballot, we'd win tomorrow easily.<p style="background-color: rgba(224, 224, 224, 0.2); text-align: left; box-sizing: border-box; margin-bottom: 1rem; margin-top: 0px;" times="Times" new="New" roman="Roman" serif="serif" font-size="font-size" px="px" line-height="line-height" rem="rem" color="color" rgb="rgb" background-color="background-color">Q: A lot of people in the legalization space are worried that Big Pharma will try to keep marijuana from becoming legal so it can't compete with their existing products. Are those concerns warranted?<p style="background-color: rgba(224, 224, 224, 0.2); text-align: left; box-sizing: border-box; margin-bottom: 1rem; margin-top: 0px;" times="Times" new="New" roman="Roman" serif="serif" font-size="font-size" px="px" line-height="line-height" rem="rem" color="color" rgb="rgb" background-color="background-color">A: The pharmaceutical industry is all about finding new medicines, and when it's legally possible for them to go to the [Food and Drug Administration] with medical marijuana products, they're going to be doing that. They're probably going to come around to cannabis entrepreneurs who've pioneered these medicines, and they're going to want to talk to you about acquiring your companies one day. But I don't think they're going to fight it.  Q: Donald Trump said he would sign a bill returning marijuana laws and regulation to the states. Are you confident Congress will actually vote on something and Trump will sign it?...<p style="background-color: rgba(224, 224, 224, 0.2); text-align: left; box-sizing: border-box; margin-bottom: 1rem; margin-top: 0px;" times="Times" new="New" roman="Roman" serif="serif" font-size="font-size" px="px" line-height="line-height" rem="rem" color="color" rgb="rgb" background-color="background-color">=Former congressional staffer and established lobbyist John Blount has joined Tauzin Consultants.Blount started work for Tauzin in January, and brought six clients along with him from Capitol Hill Consulting Group, where he had worked as senior vice president.“John Blount is great addition to our small yet growing business. His extensive experience on and off the Hill strengthens Tauzin Consultants and the services we provide immeasurably,” Tauzin Consultants said in a statement to The Hill.“We very much look forward to including such a senior legislative expert within our ranks.”Blount had been with Capitol Hill Consulting Group since 2007. He confirmed to The Hill that six of his clients — DBA International, SCAN Health Plan, GSM Integrated Controls USA, the Committee to Save Independent HME Suppliers, the Industrial Safety Training Council and the Bituminous Coal Operators Association — followed him to the new firm. Capitol Hill Consulting Group recently filed termination reports for those clients. Tauzin Consultants is the new lobbying venture of former Rep. Billy Tauzin (R-La.), who retired from politics in 2005 and became the president and CEO of PhRMA, the top lobbying group for the drug industry. After leaving PhRMA in 2010, he co-founded Tauzin Consultants with his son, Thomas Tauzin.  Thomas Tauzin also previously worked for Capitol Hill Consulting Group.Blount served as a senior aide to three Republican members of the House during his time on Capitol Hill, including the late Rep. Bill Emerson (R-Mo.). He has also worked for the National Association of Realtors, where he lobbied for a decade. This isn’t the first time some of his clients have stuck with Blount. The Industrial Safety Training Council has followed him through several firms, and the Bituminous Coal Operators Association has worked with him since 1999.  Capitol Hill Consulting Group did not provide a statement on Blount’s departure.<a href="https://www.opensecrets.org/lobby/firmsum.php?id=D000067297">https://www.opensecrets.org/lobby/firmsum.php?id=D000067297</a>2017<table class="datadisplay" id="firm_issues" style="background: rgb(224, 230, 236); border-collapse: collapse; border-spacing: 0px; margin: 0.5em 0px 1em; padding: 0px; width: 574px;" open="Open" sans="Sans" helvetica="Helvetica" arial="Arial" sans-serif="sans-serif" font-size="font-size" px="px"><thead><tr style="background-color: rgb(240, 243, 246);"><th class="data" style="padding: 3px; text-align: center; background: rgb(153, 153, 153);">Issue</th><th class="data" style="padding: 3px; text-align: center; background: rgb(153, 153, 153);">No. of Reports*</th><th class="data" style="padding: 3px; text-align: center; background: rgb(153, 153, 153);">No. of Lobbyists</th></tr></thead><tbody><tr><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=TRA&year=2017" style="background: transparent; text-decoration-line: none;">Transportation</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">12</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">3</td></tr><tr style="background-color: rgb(240, 243, 246);"><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=DIS&year=2017" style="background: transparent; text-decoration-line: none;">Disaster & Emergency Planning</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">9</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">4</td></tr><tr><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=ENV&year=2017" style="background: transparent; text-decoration-line: none;">Environment & Superfund</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">7</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">3</td></tr><tr style="background-color: rgb(240, 243, 246);"><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=MAR&year=2017" style="background: transparent; text-decoration-line: none;">Marine, Boats & Fisheries</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">6</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">3</td></tr><tr><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=HOM&year=2017" style="background: transparent; text-decoration-line: none;">Homeland Security</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">6</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">4</td></tr><tr style="background-color: rgb(240, 243, 246);"><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=ENG&year=2017" style="background: transparent; text-decoration-line: none;">Energy & Nuclear Power</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">3</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">3</td></tr><tr><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=BUD&year=2017" style="background: transparent; text-decoration-line: none;">Fed Budget & Appropriations</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">3</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">3</td></tr><tr style="background-color: rgb(240, 243, 246);"><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=TAX&year=2017" style="background: transparent; text-decoration-line: none;">Taxes</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">3</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">4</td></tr><tr><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=FIN&year=2017" style="background: transparent; text-decoration-line: none;">Finance</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">3</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">3</td></tr><tr style="background-color: rgb(240, 243, 246);"><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=COM&year=2017" style="background: transparent; text-decoration-line: none;">Radio & TV Broadcasting</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">3</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">4</td></tr><tr><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=TEC&year=2017" style="background: transparent; text-decoration-line: none;">Telecommunications</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">3</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">4</td></tr><tr style="background-color: rgb(240, 243, 246);"><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=VET&year=2017" style="background: transparent; text-decoration-line: none;">Veterans Affairs</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">1</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">2</td></tr><tr><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=HCR&year=2017" style="background: transparent; text-decoration-line: none;">Health Issues</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">1</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">4</td></tr><tr style="background-color: rgb(240, 243, 246);"><td nowrap="" align="left" style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/issuesum.php?id=FUE&year=2017" style="background: transparent; text-decoration-line: none;">Fuel, Gas & Oil</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">1</td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">2</td></tr></tbody></table><table class="datadisplay" id="client_issues" style="background: rgb(224, 230, 236); border-collapse: collapse; border-spacing: 0px; margin: 0.5em 0px 1em; padding: 0px; width: 574px;"><tbody><tr><td style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/agencysum.php?id=002&year=2017" style="background: transparent; text-decoration-line: none;">US House of Representatives</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">12</td></tr><tr style="background-color: rgb(240, 243, 246);"><td style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/agencysum.php?id=001&year=2017" style="background: transparent; text-decoration-line: none;">US Senate</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">12</td></tr><tr><td style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/agencysum.php?id=200&year=2017" style="background: transparent; text-decoration-line: none;">Army Corps of Engineers</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">7</td></tr><tr style="background-color: rgb(240, 243, 246);"><td style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/agencysum.php?id=056&year=2017" style="background: transparent; text-decoration-line: none;">Federal Emergency Management Agency</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">3</td></tr><tr><td style="padding: 5px; vertical-align: top;"><a href="https://www.opensecrets.org/lobby/agencysum.php?id=093&year=2017" style="background: transparent; text-decoration-line: none;">Trade & Development Agency</a></td><td class="center" style="padding: 5px; text-align: center; vertical-align: top;">1</td></tr></tbody></table>==<a href="http://www.sourcewatch.org/index.php?title=Billy_Tauzin" title="Billy Tauzin">Billy Tauzin</a>: Former chair of the the <a href="http://www.sourcewatch.org/index.php?title=Energy_and_Commerce_Committee" title="Energy and Commerce Committee" class="mw-redirect" style="font-family: " times="Times" new="New" roman="Roman" font-size="font-size" large="large">Energy and Commerce Committee</a>, which had oversight of the drug industry, who after retiring from Congress in late 2004 started as head of <a href="http://www.sourcewatch.org/index.php?title=Pharmaceutical_Research_and_Manufacturers_of_America" title="Pharmaceutical Research and Manufacturers of America" style="font-family: " times="Times" new="New" roman="Roman" font-size="font-size" large="large">Pharmaceutical Research and Manufacturers of America</a> in January 2005.

gift keeps giving; premium up 22%2m$ yr negot ACA w/BO to keep status quo on drugs, cf 2016 ca prop naacp ca sellout huffman<div class="g" style="background-color: rgb(255, 255, 255); line-height: 1.2; margin-top: 0px; margin-bottom: 23px;"><div class="rc" data-hveid="29" style="position: relative;"><h3 class="r" style="text-align: left; font-weight: normal; margin: 0px; padding: 0px; overflow: hidden; text-overflow: ellipsis; white-space: nowrap;"><a href="https://en.wikipedia.org/wiki/Billy_Tauzin" style="cursor: pointer; text-decoration: none;">Billy Tauzin - Wikipedia</a></h3><div class="s" style="max-width: 48em; line-height: 18px;"><div class="f kv SWb" style="height: 17px; line-height: 16px; white-space: nowrap;"><div style="text-align: left;">https://en.wikipedia.org/wiki/BillyTauzin</div><div class="action-menu ab_ctl" style="display: inline; position: relative; margin: 0px 3px; vertical-align: middle; -webkit-user-select: none;"><a class="Fmb ab_button" href="https://www.google.com/search?q=billy+tauzin+pharma&oq=billy+tauzin+pharma&aqs=chrome..69i57j0.5127j0j4&sourceid=chrome&ie=UTF-8#" id="am-b0" aria-label="Result details" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q7B0IHzAA" style="border-radius: 0px; cursor: default; font-weight: bold; height: 12px; line-height: 27px; margin: 0px; min-width: 0px; padding: 0px; text-align: center; transition: none 0s ease 0s; user-select: none; background-image: none; border: 0px; box-shadow: 0px 0px 0px 0px; filter: none; width: 13px; text-decoration: none; display: inline-block;"><span class="mn-dwn-arw" style="text-align: left; border-color: rgb(0, 102, 33) transparent; border-style: solid; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -4px; position: absolute; left: 0px; border-width: 5px 4px 0px !important;" /></a><div class="action-menu-panel ab_dropdown" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QqR8IIDAA" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border: 1px solid rgba(0, 0, 0, 0.2); padding: 0px; position: absolute; right: auto; top: 12px; z-index: 3; transition: opacity 0.218s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px; left: 0px; visibility: hidden;"><ol style="margin: 0px; padding: 0px; border: 0px;"><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:BLggrXlOfmQJ:https://en.wikipedia.org/wiki/Billy_Tauzin+&cd=1&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div><div class="crc" style="display: inline-block; position: relative; margin-left: 4px;"><div class="crl" data-async-context="res:0;ri:;site:en.wikipedia.org" data-async-trigger="cra-0-filled" jsaction="crd.tglpop" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q5CsIIzAA" style="display: inline-block; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><div style="text-align: left;"><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-decoration-line: none; cursor: pointer; padding: 7px 18px; outline: 0px; display: inline !important;">Wikipedia</a></div><span class="Bs" style="text-align: left; border-width: 4px 4px 0px; border-style: solid; width: 0px; height: 0px; top: 8.5px; position: absolute; margin-left: 6px; margin-top: -3px; border-color: rgb(170, 170, 170) transparent !important;" /></div></div></div><a class="fl" href="https://www.google.com/search?q=related:https://en.wikipedia.org/wiki/Billy_Tauzin+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgiMAA" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;">Jump to </a><div style="text-align: left;"><a class="fl" href="https://en.wikipedia.org/wiki/Billy_Tauzin#Connections_to_pharmaceutical_industry" style="text-decoration-line: none; cursor: pointer;">Connections to pharmaceutical industry</a> - Wilbert Joseph "Billy" Tauzin II is an American lobbyist and politician. He was President and CEO of ...</div><div class="osl" style="text-align: left; margin-top: 0px;">‎<a class="fl" href="https://en.wikipedia.org/wiki/Billy_Tauzin#Personal_life" style="text-decoration: none; cursor: pointer;">Personal life</a> · ‎<a class="fl" href="https://en.wikipedia.org/wiki/Billy_Tauzin#Political_career" style="text-decoration: none; cursor: pointer;">Political career</a> · ‎<a class="fl" href="https://en.wikipedia.org/wiki/Billy_Tauzin#Career_as_a_lobbyist" style="text-decoration: none; cursor: pointer;">Career as a lobbyist</a> · ‎<a class="fl" href="https://en.wikipedia.org/wiki/Billy_Tauzin#Controversies" style="text-decoration: none; cursor: pointer;">Controversies</a></div></div></div></div><div class="g" style="background-color: rgb(255, 255, 255); line-height: 1.2; margin-top: 0px; margin-bottom: 23px;"><div class="rc" data-hveid="42" style="position: relative;"><h3 class="r" style="text-align: left; font-weight: normal; margin: 0px; padding: 0px; overflow: hidden; text-overflow: ellipsis; white-space: nowrap;"><a href="https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/" style="cursor: pointer; text-decoration: none;">The Legacy of Billy Tauzin: The White House-PhRMA Deal - Sunlight ...</a></h3><div class="s" style="max-width: 48em; line-height: 18px;"><div class="f kv SWb" style="height: 17px; line-height: 16px; white-space: nowrap;"><div style="text-align: left;">https://sunlightfoundation.com/.../the-legacy-of-billy-tauzin-the-...</div><div class="action-menu ab_ctl" style="display: inline; position: relative; margin: 0px 3px; vertical-align: middle; -webkit-user-select: none;"><a class="Fmb ab_button" href="https://www.google.com/search?q=billy+tauzin+pharma&oq=billy+tauzin+pharma&aqs=chrome..69i57j0.5127j0j4&sourceid=chrome&ie=UTF-8#" id="am-b1" aria-label="Result details" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q7B0ILDAB" style="border-radius: 0px; cursor: default; font-weight: bold; height: 12px; line-height: 27px; margin: 0px; min-width: 0px; padding: 0px; text-align: center; transition: none 0s ease 0s; user-select: none; background-image: none; border: 0px; box-shadow: 0px 0px 0px 0px; filter: none; width: 13px; text-decoration: none; display: inline-block;"><span class="mn-dwn-arw" style="text-align: left; border-color: rgb(0, 102, 33) transparent; border-style: solid; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -4px; position: absolute; left: 0px; border-width: 5px 4px 0px !important;" /></a><div class="action-menu-panel ab_dropdown" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QqR8ILTAB" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border: 1px solid rgba(0, 0, 0, 0.2); padding: 0px; position: absolute; right: auto; top: 12px; z-index: 3; transition: opacity 0.218s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px; left: 0px; visibility: hidden;"><ol style="margin: 0px; padding: 0px; border: 0px;"><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:UM346N2X8qwJ:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+&cd=2&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div><div class="crc" style="display: inline-block; position: relative; margin-left: 4px;"><div class="crl" data-async-context="res:1;ri:;site:sunlightfoundation.com" data-async-trigger="cra-1-filled" jsaction="crd.tglpop" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q5CsIMDAB" style="display: inline-block; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><div style="text-align: left;"><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-decoration-line: none; cursor: pointer; padding: 7px 18px; outline: 0px; display: inline !important;">Sunlight Foundation</a></div><span class="Bs" style="text-align: left; border-width: 4px 4px 0px; border-style: solid; width: 0px; height: 0px; top: 8.5px; position: absolute; margin-left: 6px; margin-top: -3px; border-color: rgb(170, 170, 170) transparent !important;" /></div></div></div><a class="fl" href="https://www.google.com/search?q=related:https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwgvMAE" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;">Feb 12, 2010 - Early on, the pharmaceutical companies were told to deal directly with ... In attendance were Billy Tauzin, president, CEO and top lobbyist for ...</a></div></div></div><div class="g" style="background-color: rgb(255, 255, 255); line-height: 1.2; margin-top: 0px; margin-bottom: 23px;"><div class="rc" data-hveid="50" style="position: relative;"><h3 class="r" style="text-align: left; font-weight: normal; margin: 0px; padding: 0px; overflow: hidden; text-overflow: ellipsis; white-space: nowrap;"><a href="http://billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/" style="cursor: pointer; text-decoration: none;">The Lobbyist Who Made You Pay More at the Drugstore - BillMoyers ...</a></h3><div class="s" style="max-width: 48em; line-height: 18px;"><div class="f kv _SWb" style="height: 17px; line-height: 16px; white-space: nowrap;"><div style="text-align: left;">billmoyers.com/.../the-man-who-made-you-pay-more-at-the-drugstore/</div><div class="action-menu ab_ctl" style="display: inline; position: relative; margin: 0px 3px; vertical-align: middle; -webkit-user-select: none;"><a class="Fmb ab_button" href="https://www.google.com/search?q=billy+tauzin+pharma&oq=billy+tauzin+pharma&aqs=chrome..69i57j0.5127j0j4&sourceid=chrome&ie=UTF-8#" id="am-b2" aria-label="Result details" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q7B0INDAC" style="border-radius: 0px; cursor: default; font-weight: bold; height: 12px; line-height: 27px; margin: 0px; min-width: 0px; padding: 0px; text-align: center; transition: none 0s ease 0s; user-select: none; background-image: none; border: 0px; box-shadow: 0px 0px 0px 0px; filter: none; width: 13px; text-decoration: none; display: inline-block;"><span class="mn-dwn-arw" style="text-align: left; border-color: rgb(0, 102, 33) transparent; border-style: solid; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -4px; position: absolute; left: 0px; border-width: 5px 4px 0px !important;" /></a><div class="action-menu-panel ab_dropdown" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QqR8INTAC" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border: 1px solid rgba(0, 0, 0, 0.2); padding: 0px; position: absolute; right: auto; top: 12px; z-index: 3; transition: opacity 0.218s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px; left: 0px; visibility: hidden;"><ol style="margin: 0px; padding: 0px; border: 0px;"><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div><div class="crc" style="display: inline-block; position: relative; margin-left: 4px;"><div class="crl" data-async-context="res:2;ri:;site:billmoyers.com" data-async-trigger="cra-2-filled" jsaction="crd.tglpop" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q5CsINzAC" style="display: inline-block; cursor: pointer;"><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><div style="text-align: left;"><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-decoration-line: none; cursor: pointer; padding: 7px 18px; outline: 0px; display: inline !important;">Bill D. Moyers</a></div><span class="Bs" style="text-align: left; border-width: 4px 4px 0px; border-style: solid; width: 0px; height: 0px; top: 8.5px; position: absolute; margin-left: 6px; margin-top: -3px; border-color: rgb(170, 170, 170) transparent !important;" /></div></div></div><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:l65Fz9Dbd_8J:billmoyers.com/story/the-man-who-made-you-pay-more-at-the-drugstore/+&cd=3&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;">Mar 18, 2016 - Here's how the pharmaceutical industry keeps America's drug prices ... Bill and Faith Wildrick have never heard of Billy Tauzin, but they're ...</a></div></div></div><div class="g" style="background-color: rgb(255, 255, 255); line-height: 1.2; margin-top: 0px; margin-bottom: 23px;"><div class="rc" data-hveid="57" style="position: relative;"><h3 class="r" style="text-align: left; font-weight: normal; margin: 0px; padding: 0px; overflow: hidden; text-overflow: ellipsis; white-space: nowrap;"><a href="http://www.nytimes.com/2010/02/13/health/policy/13pharm.html" style="cursor: pointer; text-decoration: none;">One Deal Too Many Costs Billy Tauzin His Job - The New York Times</a></h3><div class="s" style="max-width: 48em; line-height: 18px;"><div class="f kv _SWb" style="height: 17px; line-height: 16px; white-space: nowrap;"><div style="text-align: left;">www.nytimes.com/2010/02/13/health/policy/13pharm.html</div><div class="action-menu ab_ctl" style="display: inline; position: relative; margin: 0px 3px; vertical-align: middle; -webkit-user-select: none;"><a class="Fmb ab_button" href="https://www.google.com/search?q=billy+tauzin+pharma&oq=billy+tauzin+pharma&aqs=chrome..69i57j0.5127j0j4&sourceid=chrome&ie=UTF-8#" id="am-b3" aria-label="Result details" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q7B0IOzAD" style="border-radius: 0px; cursor: default; font-weight: bold; height: 12px; line-height: 27px; margin: 0px; min-width: 0px; padding: 0px; text-align: center; transition: none 0s ease 0s; user-select: none; background-image: none; border: 0px; box-shadow: 0px 0px 0px 0px; filter: none; width: 13px; text-decoration: none; display: inline-block;"><span class="mn-dwn-arw" style="text-align: left; border-color: rgb(0, 102, 33) transparent; border-style: solid; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -4px; position: absolute; left: 0px; border-width: 5px 4px 0px !important;" /></a><div class="action-menu-panel ab_dropdown" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QqR8IPDAD" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border: 1px solid rgba(0, 0, 0, 0.2); padding: 0px; position: absolute; right: auto; top: 12px; z-index: 3; transition: opacity 0.218s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px; left: 0px; visibility: hidden;"><ol style="margin: 0px; padding: 0px; border: 0px;"><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div><div class="crc" style="display: inline-block; position: relative; margin-left: 4px;"><div class="crl" data-async-context="res:3;ri:;site:nytimes.com" data-async-trigger="cra-3-filled" jsaction="crd.tglpop" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q5CsIPjAD" style="display: inline-block; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><div style="text-align: left;"><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-decoration-line: none; cursor: pointer; padding: 7px 18px; outline: 0px; display: inline !important;">The New York Times</a></div><span class="Bs" style="text-align: left; border-width: 4px 4px 0px; border-style: solid; width: 0px; height: 0px; top: 8.5px; position: absolute; margin-left: 6px; margin-top: -3px; border-color: rgb(170, 170, 170) transparent !important;" /></div></div></div><a class="fl" href="https://www.google.com/search?q=related:www.nytimes.com/2010/02/13/health/policy/13pharm.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwg9MAM" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;">Feb 12, 2010 - Billy Tauzin is leaving his $2 million job amid drug makers' ... the PharmaceuticalResearch and Manufacturers of America, known as PhRMA, ...</a></div></div></div><div class="g" style="background-color: rgb(255, 255, 255); line-height: 1.2; margin-top: 0px; margin-bottom: 23px;"><div class="rc" data-hveid="64" style="position: relative;"><h3 class="r" style="text-align: left; font-weight: normal; margin: 0px; padding: 0px; overflow: hidden; text-overflow: ellipsis; white-space: nowrap;"><a href="http://www.wsj.com/articles/SB10001424052970204251404574342700476613702" style="cursor: pointer; text-decoration: none;">Billy Tauzin Sells Out Big Pharma for $80 billion in Prescription Drug ...</a></h3><div class="s" style="max-width: 48em; line-height: 18px;"><div class="f kv _SWb" style="height: 17px; line-height: 16px; white-space: nowrap;"><div style="text-align: left;">www.wsj.com/.../SB10001424052970204251404574342700...</div><div class="action-menu ab_ctl" style="display: inline; position: relative; margin: 0px 3px; vertical-align: middle; -webkit-user-select: none;"><a class="Fmb ab_button" href="https://www.google.com/search?q=billy+tauzin+pharma&oq=billy+tauzin+pharma&aqs=chrome..69i57j0.5127j0j4&sourceid=chrome&ie=UTF-8#" id="am-b4" aria-label="Result details" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q7B0IQjAE" style="border-radius: 0px; cursor: default; font-weight: bold; height: 12px; line-height: 27px; margin: 0px; min-width: 0px; padding: 0px; text-align: center; transition: none 0s ease 0s; user-select: none; background-image: none; border: 0px; box-shadow: 0px 0px 0px 0px; filter: none; width: 13px; text-decoration: none; display: inline-block;"><span class="mn-dwn-arw" style="text-align: left; border-color: rgb(0, 102, 33) transparent; border-style: solid; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -4px; position: absolute; left: 0px; border-width: 5px 4px 0px !important;" /></a><div class="action-menu-panel ab_dropdown" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QqR8IQzAE" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border: 1px solid rgba(0, 0, 0, 0.2); padding: 0px; position: absolute; right: auto; top: 12px; z-index: 3; transition: opacity 0.218s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px; left: 0px; visibility: hidden;"><ol style="margin: 0px; padding: 0px; border: 0px;"><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div><div class="crc" style="display: inline-block; position: relative; margin-left: 4px;"><div class="crl" data-async-context="res:4;ri:;site:wsj.com" data-async-trigger="cra-4-filled" jsaction="crd.tglpop" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q5CsIRTAE" style="display: inline-block; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><div style="text-align: left;"><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-decoration-line: none; cursor: pointer; padding: 7px 18px; outline: 0px; display: inline !important;">The Wall Street Journal</a></div><span class="Bs" style="text-align: left; border-width: 4px 4px 0px; border-style: solid; width: 0px; height: 0px; top: 8.5px; position: absolute; margin-left: 6px; margin-top: -3px; border-color: rgb(170, 170, 170) transparent !important;" /></div></div></div><a class="fl" href="https://www.google.com/search?q=related:www.wsj.com/articles/SB10001424052970204251404574342700476613702+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhEMAQ" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;">Aug 13, 2009 - The Wall Street Journal writes that Big Pharma lobbyist Billy Tauzin has traded away his industry for $80 billion in prescription-drug discounts, ...</a></div></div></div><div class="g" style="background-color: rgb(255, 255, 255); line-height: 1.2; margin-top: 0px; margin-bottom: 23px;"><div class="rc" data-hveid="71" style="position: relative;"><h3 class="r" style="text-align: left; font-weight: normal; margin: 0px; padding: 0px; overflow: hidden; text-overflow: ellipsis; white-space: nowrap;"><a href="http://www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html" style="cursor: pointer; text-decoration: none;">How Big Pharma's Billy Tauzin conned the White House out of $76 ...</a></h3><div class="s" style="max-width: 48em; line-height: 18px;"><div class="f kv _SWb" style="height: 17px; line-height: 16px; white-space: nowrap;"><div style="text-align: left;">www.slate.com/articles/news.../obamas_biggest_health_reform_blunder.html</div><div class="action-menu ab_ctl" style="display: inline; position: relative; margin: 0px 3px; vertical-align: middle; -webkit-user-select: none;"><a class="Fmb ab_button" href="https://www.google.com/search?q=billy+tauzin+pharma&oq=billy+tauzin+pharma&aqs=chrome..69i57j0.5127j0j4&sourceid=chrome&ie=UTF-8#" id="am-b5" aria-label="Result details" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q7B0ISTAF" style="border-radius: 0px; cursor: default; font-weight: bold; height: 12px; line-height: 27px; margin: 0px; min-width: 0px; padding: 0px; text-align: center; transition: none 0s ease 0s; user-select: none; background-image: none; border: 0px; box-shadow: 0px 0px 0px 0px; filter: none; width: 13px; text-decoration: none; display: inline-block;"><span class="mn-dwn-arw" style="text-align: left; border-color: rgb(0, 102, 33) transparent; border-style: solid; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -4px; position: absolute; left: 0px; border-width: 5px 4px 0px !important;" /></a><div class="action-menu-panel ab_dropdown" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QqR8ISjAF" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border: 1px solid rgba(0, 0, 0, 0.2); padding: 0px; position: absolute; right: auto; top: 12px; z-index: 3; transition: opacity 0.218s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px; left: 0px; visibility: hidden;"><ol style="margin: 0px; padding: 0px; border: 0px;"><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:aahNv_W66EgJ:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+&cd=6&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div><div class="crc" style="display: inline-block; position: relative; margin-left: 4px;"><div class="crl" data-async-context="res:5;ri:;site:slate.com" data-async-trigger="cra-5-filled" jsaction="crd.tglpop" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q5CsITTAF" style="display: inline-block; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><div style="text-align: left;"><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-decoration-line: none; cursor: pointer; padding: 7px 18px; outline: 0px; display: inline !important;">Slate</a></div><span class="Bs" style="text-align: left; border-width: 4px 4px 0px; border-style: solid; width: 0px; height: 0px; top: 8.5px; position: absolute; margin-left: 6px; margin-top: -3px; border-color: rgb(170, 170, 170) transparent !important;" /></div></div></div><a class="fl" href="https://www.google.com/search?q=related:www.slate.com/articles/news_and_politics/prescriptions/2009/08/obamas_biggest_health_reform_blunder.html+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhMMAU" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;">Aug 6, 2009 - Billy Tauzin, president of the Pharmaceutical Research and Manufacturers of America, has cut a secret deal on health reform with the White ...</a></div></div></div><div class="g" style="background-color: rgb(255, 255, 255); line-height: 1.2; margin-top: 0px; margin-bottom: 23px;"><div class="rc" data-hveid="79" style="position: relative;"><h3 class="r" style="text-align: left; font-weight: normal; margin: 0px; padding: 0px; overflow: hidden; text-overflow: ellipsis; white-space: nowrap;"><a href="http://www.cbsnews.com/news/under-the-influence/" style="cursor: pointer; text-decoration: none;">Under The Influence - CBS News</a></h3><div class="s" style="max-width: 48em; line-height: 18px;"><div class="f kv _SWb" style="height: 17px; line-height: 16px; white-space: nowrap;"><div style="text-align: left;">www.cbsnews.com/news/under-the-influence/</div><div class="action-menu ab_ctl" style="display: inline; position: relative; margin: 0px 3px; vertical-align: middle; -webkit-user-select: none;"><a class="Fmb ab_button" href="https://www.google.com/search?q=billy+tauzin+pharma&oq=billy+tauzin+pharma&aqs=chrome..69i57j0.5127j0j4&sourceid=chrome&ie=UTF-8#" id="am-b6" aria-label="Result details" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q7B0IUTAG" style="border-radius: 0px; cursor: default; font-weight: bold; height: 12px; line-height: 27px; margin: 0px; min-width: 0px; padding: 0px; text-align: center; transition: none 0s ease 0s; user-select: none; background-image: none; border: 0px; box-shadow: 0px 0px 0px 0px; filter: none; width: 13px; text-decoration: none; display: inline-block;"><span class="mn-dwn-arw" style="text-align: left; border-color: rgb(0, 102, 33) transparent; border-style: solid; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -4px; position: absolute; left: 0px; border-width: 5px 4px 0px !important;" /></a><div class="action-menu-panel ab_dropdown" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QqR8IUjAG" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border: 1px solid rgba(0, 0, 0, 0.2); padding: 0px; position: absolute; right: auto; top: 12px; z-index: 3; transition: opacity 0.218s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px; left: 0px; visibility: hidden;"><ol style="margin: 0px; padding: 0px; border: 0px;"><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:YVSh1EhAaewJ:www.cbsnews.com/news/under-the-influence/+&cd=7&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div><div class="crc" style="display: inline-block; position: relative; margin-left: 4px;"><div class="crl" data-async-context="res:6;ri:;site:cbsnews.com" data-async-trigger="cra-6-filled" jsaction="crd.tglpop" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q5CsIVTAG" style="display: inline-block; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><div style="text-align: left;"><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-decoration-line: none; cursor: pointer; padding: 7px 18px; outline: 0px; display: inline !important;">CBS News</a></div><span class="Bs" style="text-align: left; border-width: 4px 4px 0px; border-style: solid; width: 0px; height: 0px; top: 8.5px; position: absolute; margin-left: 6px; margin-top: -3px; border-color: rgb(170, 170, 170) transparent !important;" /></div></div></div><a class="fl" href="https://www.google.com/search?q=related:www.cbsnews.com/news/under-the-influence/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhUMAY" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;">"The pharmaceutical lobbyists wrote the bill," says Jones. ... of the credit went to former Congressman Billy Tauzin, R-La., who steered it through the house.</a></div></div></div><div class="g" style="background-color: rgb(255, 255, 255); line-height: 1.2; margin-top: 0px; margin-bottom: 23px;"><div class="rc" data-hveid="86" style="position: relative;"><h3 class="r" style="text-align: left; font-weight: normal; margin: 0px; padding: 0px; overflow: hidden; text-overflow: ellipsis; white-space: nowrap;"><a href="https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/" style="cursor: pointer; text-decoration: none;">Pharmaceutical industry, under scrutiny for prices, has history of big ...</a></h3><div class="s" style="max-width: 48em; line-height: 18px;"><div class="f kv _SWb" style="height: 17px; line-height: 16px; white-space: nowrap;"><div style="text-align: left;">https://www.opensecrets.org/.../pharmaceutical-industry-...</div><div class="action-menu ab_ctl" style="display: inline; position: relative; margin: 0px 3px; vertical-align: middle; -webkit-user-select: none;"><a class="Fmb ab_button" href="https://www.google.com/search?q=billy+tauzin+pharma&oq=billy+tauzin+pharma&aqs=chrome..69i57j0.5127j0j4&sourceid=chrome&ie=UTF-8#" id="am-b7" aria-label="Result details" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q7B0IWDAH" style="border-radius: 0px; cursor: default; font-weight: bold; height: 12px; line-height: 27px; margin: 0px; min-width: 0px; padding: 0px; text-align: center; transition: none 0s ease 0s; user-select: none; background-image: none; border: 0px; box-shadow: 0px 0px 0px 0px; filter: none; width: 13px; text-decoration: none; display: inline-block;"><span class="mn-dwn-arw" style="text-align: left; border-color: rgb(0, 102, 33) transparent; border-style: solid; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -4px; position: absolute; left: 0px; border-width: 5px 4px 0px !important;" /></a><div class="action-menu-panel ab_dropdown" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QqR8IWTAH" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border: 1px solid rgba(0, 0, 0, 0.2); padding: 0px; position: absolute; right: auto; top: 12px; z-index: 3; transition: opacity 0.218s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px; left: 0px; visibility: hidden;"><ol style="margin: 0px; padding: 0px; border: 0px;"><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div><div class="crc" style="display: inline-block; position: relative; margin-left: 4px;"><div class="crl" data-async-context="res:7;ri:;site:opensecrets.org" data-async-trigger="cra-7-filled" jsaction="crd.tglpop" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q5CsIWzAH" style="display: inline-block; cursor: pointer;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><div style="text-align: left;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-decoration-line: none; cursor: pointer; padding: 7px 18px; outline: 0px; display: inline !important;">Center for Responsive Politics</a></div><span class="Bs" style="text-align: left; border-width: 4px 4px 0px; border-style: solid; width: 0px; height: 0px; top: 8.5px; position: absolute; margin-left: 6px; margin-top: -3px; border-color: rgb(170, 170, 170) transparent !important;" /></div></div></div><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:MSfnbwXEpxIJ:https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/+&cd=8&hl=en&ct=clnk&gl=us" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;">Oct 2, 2015 - Billy Tauzin in 2010, when he headed the Pharmaceutical Research and Manufacturers of America (PhRMA). (CQ Roll Call via AP Images).</a></div></div></div><div class="g" style="background-color: rgb(255, 255, 255); line-height: 1.2; margin-top: 0px; margin-bottom: 23px;"><div class="rc" data-hveid="93" style="position: relative;"><h3 class="r" style="text-align: left; font-weight: normal; margin: 0px; padding: 0px; overflow: hidden; text-overflow: ellipsis; white-space: nowrap;"><a href="http://thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm" style="cursor: pointer; text-decoration: none;">Former Rep. Billy Tauzin joins son's lobby firm | TheHill</a></h3><div class="s" style="max-width: 48em; line-height: 18px;"><div class="f kv _SWb" style="height: 17px; line-height: 16px; white-space: nowrap;"><div style="text-align: left;">thehill.com/business-a-lobbying/.../206792-billy-tauzin-joins-sons-lobby-firm</div><div class="action-menu ab_ctl" style="display: inline; position: relative; margin: 0px 3px; vertical-align: middle; -webkit-user-select: none;"><a class="Fmb ab_button" href="https://www.google.com/search?q=billy+tauzin+pharma&oq=billy+tauzin+pharma&aqs=chrome..69i57j0.5127j0j4&sourceid=chrome&ie=UTF-8#" id="am-b8" aria-label="Result details" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q7B0IXzAI" style="border-radius: 0px; cursor: default; font-weight: bold; height: 12px; line-height: 27px; margin: 0px; min-width: 0px; padding: 0px; text-align: center; transition: none 0s ease 0s; user-select: none; background-image: none; border: 0px; box-shadow: 0px 0px 0px 0px; filter: none; width: 13px; text-decoration: none; display: inline-block;"><span class="mn-dwn-arw" style="text-align: left; border-color: rgb(0, 102, 33) transparent; border-style: solid; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -4px; position: absolute; left: 0px; border-width: 5px 4px 0px !important;" /></a><div class="action-menu-panel ab_dropdown" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QqR8IYDAI" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border: 1px solid rgba(0, 0, 0, 0.2); padding: 0px; position: absolute; right: auto; top: 12px; z-index: 3; transition: opacity 0.218s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px; left: 0px; visibility: hidden;"><ol style="margin: 0px; padding: 0px; border: 0px;"><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:IJM6-xqBIJ:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+&cd=9&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div><div class="crc" style="display: inline-block; position: relative; margin-left: 4px;"><div class="crl" data-async-context="res:8;ri:;site:thehill.com" data-async-trigger="cra-8-filled" jsaction="crd.tglpop" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q5CsIYzAI" style="display: inline-block; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><div style="text-align: left;"><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-decoration-line: none; cursor: pointer; padding: 7px 18px; outline: 0px; display: inline !important;">The Hill</a></div><span class="Bs" style="text-align: left; border-width: 4px 4px 0px; border-style: solid; width: 0px; height: 0px; top: 8.5px; position: absolute; margin-left: 6px; margin-top: -3px; border-color: rgb(170, 170, 170) transparent !important;" /></div></div></div><a class="fl" href="https://www.google.com/search?q=related:thehill.com/business-a-lobbying/lobbying-hires/206792-billy-tauzin-joins-sons-lobby-firm+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhiMAg" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;">May 21, 2014 - Billy Tauzin has left Alston & Bird to work at a lobby firm founded by his ... of thePharmaceutical Research and Manufacturers of America, the ...</a></div></div></div><div class="g" style="background-color: rgb(255, 255, 255); line-height: 1.2; margin-top: 0px; margin-bottom: 16px;"><div class="rc" data-hveid="101" style="position: relative;"><h3 class="r" style="text-align: left; font-weight: normal; margin: 0px; padding: 0px; overflow: hidden; text-overflow: ellipsis; white-space: nowrap;"><a href="http://www.huffingtonpost.com/news/billy-tauzin/" style="cursor: pointer; text-decoration: none;">Billy Tauzin - Huffington Post</a></h3><div class="s" style="max-width: 48em; line-height: 18px;"><div class="f kv _SWb" style="height: 17px; line-height: 16px; white-space: nowrap;"><div style="text-align: left;">www.huffingtonpost.com/news/billy-tauzin/</div><div class="action-menu ab_ctl" style="display: inline; position: relative; margin: 0px 3px; vertical-align: middle; -webkit-user-select: none;"><a class="Fmb ab_button" href="https://www.google.com/search?q=billy+tauzin+pharma&oq=billy+tauzin+pharma&aqs=chrome..69i57j0.5127j0j4&sourceid=chrome&ie=UTF-8#" id="am-b9" aria-label="Result details" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q7B0IZzAJ" style="border-radius: 0px; cursor: default; font-weight: bold; height: 12px; line-height: 27px; margin: 0px; min-width: 0px; padding: 0px; text-align: center; transition: none 0s ease 0s; user-select: none; background-image: none; border: 0px; box-shadow: 0px 0px 0px 0px; filter: none; width: 13px; text-decoration: none; display: inline-block;"><span class="mn-dwn-arw" style="text-align: left; border-color: rgb(0, 102, 33) transparent; border-style: solid; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -4px; position: absolute; left: 0px; border-width: 5px 4px 0px !important;" /></a><div class="action-menu-panel ab_dropdown" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QqR8IaDAJ" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border: 1px solid rgba(0, 0, 0, 0.2); padding: 0px; position: absolute; right: auto; top: 12px; z-index: 3; transition: opacity 0.218s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px; left: 0px; visibility: hidden;"><ol style="margin: 0px; padding: 0px; border: 0px;"><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="http://webcache.googleusercontent.com/search?q=cache:fiPKwJiVY4J:www.huffingtonpost.com/news/billy-tauzin/+&cd=10&hl=en&ct=clnk&gl=us" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li><li class="action-menu-item ab_dropdownitem" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; -webkit-user-select: none; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div><div class="crc" style="display: inline-block; position: relative; margin-left: 4px;"><div class="crl" data-async-context="res:9;ri:;site:huffingtonpost.com" data-async-trigger="cra-9-filled" jsaction="crd.tglpop" data-ved="0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08Q5CsIazAJ" style="display: inline-block; cursor: pointer;"><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><div style="text-align: left;"><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-decoration-line: none; cursor: pointer; padding: 7px 18px; outline: 0px; display: inline !important;">The Huffington Post</a></div><span class="Bs" style="text-align: left; border-width: 4px 4px 0px; border-style: solid; width: 0px; height: 0px; top: 8.5px; position: absolute; margin-left: 6px; margin-top: -3px; border-color: rgb(170, 170, 170) transparent !important;" /></div></div></div><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;">WASHINGTON -- When Billy Tauzin stepped down as the high-profile head of the pharmaceuticallobby in 2010, The New York Times penned his political obi.</a></div></div></div><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;">==</a><div class="entry-content" style="background-color: rgba(224, 224, 224, 0.2); margin: 5px 0px; overflow-wrap: break-word;"><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;">Soaring drug prices already had customers unhappy. The pharmaceutical industry hardly needed a new poster boy to add volume and passion to the complaints.</a><a class="fl" href="https://www.google.com/search?q=related:www.huffingtonpost.com/news/billy-tauzin/+billy+tauzin+pharma&tbo=1&sa=X&ved=0ahUKEwjIkpen8vjPAhWFg1QKHWKEA08QHwhqMAk" style="text-align: left; text-decoration: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;">But that’s just what it got last week when Martin Shkreli, the CEO of Turing Pharmaceuticals, made a name for himself after he hiked the price of a drug for AIDS and cancer patients by more than 4,000 percent. Now, some lawmakers are </a><div style="text-align: left;"><a href="http://www.washingtonpost.com/news/wonkblog/wp/2015/09/28/democrats-demand-answers-from-another-drug-company-that-jacked-up-prices/?wpmm=1&wpisrc=nl_wonk" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">scrutinizing</a> another company, Valeant Pharmaceuticals, for increasing the price of two heart drugs this year.</div>Meanwhile, Sen. Bernie Sanders (I-Vt.) and former Secretary of State Hillary Clinton, vying for the Democratic presidential nomination, have both released plans for <a href="https://berniesanders.com/issues/fighting-to-lower-prescription-drug-prices/" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">lowering</a> prescription drug <a href="https://www.hillaryclinton.com/p/briefing/factsheets/2015/09/21/hillary-clinton-plan-for-lowering-prescription-drug-costs/" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">prices</a>.The Pharmaceutical Research and Manufacturers of America, acutely aware of its image problem – 72 percent of Americans say prescription drug costs are unreasonable, according to a <a href="http://www.cbsnews.com/news/poll-americans-want-government-to-bring-down-prescription-drug-prices/" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">recent</a> Kaiser Family Foundation poll – promptly<a href="https://www.washingtonpost.com/news/to-your-health/wp/2015/09/24/why-big-pharma-hates-martin-shkreli-too/" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">distanced</a> itself from Turing (whose CEO has now said he will lower the price of Daraprim, the drug involved in the controversy). And the powerful industry trade group itself is in reboot mode with a new president and CEO, <a href="https://www.opensecrets.org/revolving/rev_summary.php?id=8861" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">Stephen Ubl</a>.There’s work to be done, for sure, but the industry has never lacked for resources to amplify its voice in politics and policy making. Since 1999, pharmaceuticals/health products has poured more money annually into lobbying <a href="http://www.opensecrets.org/lobby/top.php?showYear=2015&indexType=i" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">than any other industry</a>, including <a href="http://www.opensecrets.org/lobby/indusclient.php?id=H04&year=2014" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">$229 million</a> last year alone. PhRMA led the group, plowing <a href="http://www.opensecrets.org/lobby/clientsum.php?id=D000000504&year=2014" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">$16.6 million</a> into helping advance drugmakers’ priorities in Washington.Pharmaceutical company employees and PACs have also given big to politicians. During the last presidential cycle, federal candidates, political parties and outside spending groups received <a href="http://www.opensecrets.org/industries/totals.php?cycle=2014&ind=h04" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">$51 million</a> – the largest-ever total from the industry. In last year’s midterms, it provided $32.1 million.What’s been the return on this substantial investment? For one thing, dodging a number of bullets bearing PhRMA’s name. One of the industry’s greatest victories has been preventing Medicare from being able to negotiate drug prices with pharmaceutical companies. That was ensured when Congress passed and President George W. Bush signed the Medicare Modernization Act of 2003, which expanded Medicare to cover outpatient prescription drugs. The law also prohibited drug re-importation from Canada and Europe, where prices are often lower.<div style="text-align: left;">
</div><div style="text-align: left;">When Barack Obama was campaigning for president, he promised to resist the drug lobby. But he signed the Affordable Care Act into law in 2010 <a href="https://sunlightfoundation.com/blog/2010/02/12/the-legacy-of-billy-tauzin-the-white-house-phrma-deal/" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">without provisions</a> allowing re-importation of drugs or giving Medicare the ability to negotiate prices.Billy Tauzin, who was a Republican representative from Louisiana at the time, helped push the bill through the House. He soon after left Congress and was named president and CEO of PhRMA, which came with an annual salary of about $2 million.</div>In 2009, at the height of the debate in Congress over passing Obamacare, lobbying peaked for drugmakers at <a href="http://www.opensecrets.org/lobby/indusclient.php?id=H04&year=2009" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">$273 million</a>. PhRMA and one of its members, <a href="http://www.opensecrets.org/lobby/clientsum.php?id=D000000138&year=2009" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">Pfizer Inc</a>, each spent over $25 million to lobby that year.Running for re-election in 2012, Obama was the biggest individual recipient of pharmaceutical dollars, pulling in <a href="http://www.opensecrets.org/pres12/indus.php?id=N00009638&cycle=2012" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">$2 million</a> from the industry, which made up one of his top donor bases. His general election opponent, Mitt Romney, received almost as much at <a href="http://www.opensecrets.org/industries/recips.php?ind=h04&cycle=2012&recipdetail=A&mem=Y&sortorder=U" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">$1.98 million</a>. Obama was even more popular with the industry in <a href="http://www.opensecrets.org/industries/recips.php?ind=h04&cycle=2008&recipdetail=A&mem=Y&sortorder=U" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">2008</a>, receiving $2.5 million, while John McCain received just $800,000.This year, Obama <a href="http://www.nytimes.com/2015/04/28/us/obama-proposes-that-medicare-be-given-the-right-to-negotiate-the-cost-of-drugs.html?r=0" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">suggested</a> that lawmakers allow Medicare to negotiate down drug prices like the Department of Veterans Affairs does. But Marcia Angell, a senior lecturer at Harvard Medical School and the former editor-in-chief of the New England Journal of Medicine, said the president missed his chance when he was newly elected and Congress was under Democratic control.“That was the time to act, but he didn’t,” said Angell, a strong critic of the pharmaceutical industry.The vast majority of people surveyed in the Kaiser poll, 83 percent, want Medicare to be able to negotiate drug prices. Seventy-six percent want a limit on how much companies can charge for drugs that treat serious illnesses.Clinton’s plan, like Sanders’, would allow Medicare to bargain over drug prices. John Castellani, PhRMA’s current president and CEO, quickly fired back after Clinton released her plan last month, saying in a <a href="http://www.phrma.org/media-releases/phrma-clinton-proposal-would-turn-back-the-clock-on-medical-innovation" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">statement</a> that her “sweeping and far-reaching proposals would restrict patients’ access to medicines, result in fewer new treatments for patients, cost countless jobs across the country and erode our nation’s standing as the world leader in biomedical innovation.”Recently, pharmaceutical companies have set their sights on the <a href="https://www.congress.gov/bill/114th-congress/house-bill/6" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">21st Century Cures Act</a>, a bill to <a href="http://www.opensecrets.org/news/2015/06/phrma-companies-push-hard-on-house-bill-to-ease-testing-of-new-drugs/" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">accelerate</a> new drug approval by the Food and Drug Administration. Castellani has <a href="http://www.phrma.org/media-releases/phrma-statement-on-house-passage-of-21st-century-cures-act" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">said</a> that the legislation would help “ensure biomedical advances continue and are available to the patients who need them to live longer, healthier lives.”Critics like Diana Zuckerman, the president of the National Center for Health Research, argue that speeding up the process means smaller studies that fail to show whether a drug correlates with not only short-term changes – like, for example, a tumor shrinking over a few months – but also living longer, spending less time in the hospital and experiencing a better quality of life.But the industry has plenty of friends on Capitol Hill: During the last election cycle, pharmaceuticals employees and PACs gave <a href="http://www.opensecrets.org/industries/recips.php?ind=h04&cycle=2014&recipdetail=A&mem=Y&sortorder=U" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">hundreds of thousands of dollars</a> each to GOP congressional leaders: (soon-to-be former) House Speaker<a href="http://www.opensecrets.org/politicians/industries.php?cid=N00003675&cycle=2014" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">John Boehner</a> (R-Ohio) ($255,800), House Majority Leader <a href="http://www.opensecrets.org/politicians/industries.php?cid=N00028152&cycle=2014" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">Kevin McCarthy</a> (R-Calif.) ($253,500), Senate Majority Leader <a href="http://www.opensecrets.org/politicians/industries.php?cid=N00003389&cycle=2014" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">Mitch McConnell</a> (R-Ky.) ($363,373) and Senate Majority Whip <a href="http://www.opensecrets.org/politicians/industries.php?cid=N00024852&cycle=2014" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">John Cornyn</a> (R-Texas) ($208,050). Rep. <a href="http://www.opensecrets.org/politicians/industries.php?cid=N00004133&cycle=2014" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">Fred Upton</a> (R-Mich.), who introduced the 21st Century Cures Act, received $302,700.The largest Democratic recipients included Sens. <a href="http://www.opensecrets.org/politicians/industries.php?cid=N00000270&cycle=2014" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">Ed Markey</a> (D-Mass.) ($310,050) and <a href="http://www.opensecrets.org/politicians/industries.php?cid=N00035267&cycle=2014" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">Cory Booker</a> (D-N.J.) ($308,150), who are both members of the Senate’s Committee on Commerce, Science and Transportation, one of the congressional committees that can <a href="http://www.commerce.senate.gov/public/index.cfm/jurisdiction" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">impact</a> the industry. Former Sen. <a href="http://www.opensecrets.org/politicians/industries.php?cid=N00029617&cycle=2014" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">Kay Hagan</a> (D-N.C.), who lost reelection, accepted $284,449. The pharmaceutical industry <a href="http://www.mcclatchydc.com/news/politics-government/congress/article24764125.html" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">is an important part</a> of North Carolina’s economy.<a href="http://www.opensecrets.org/orgs/summary.php?id=D000000138" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">Pfizer Inc</a>, <a href="http://www.opensecrets.org/orgs/summary.php?id=D000000391" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">Amgen Inc</a> and <a href="http://www.opensecrets.org/orgs/summary.php?id=D000022105" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">McKesson Corp</a> were the <a href="http://www.opensecrets.org/industries/contrib.php?cycle=2014&ind=h04" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration: none;">biggest donors</a> during the 2014 cycle, with each contributing over $1 million.</div><footer class="entry-meta" style="background-color: rgba(224, 224, 224, 0.2); line-height: 15px;"><div style="text-align: left;">
</div><div style="text-align: left;">Categories: <a href="https://www.opensecrets.org/news/category/influence-lobbying/industries/" rel="category tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Industries</a> <a href="https://www.opensecrets.org/news/category/influence-lobbying/" rel="category tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Influence & Lobbying</a> <a href="https://www.opensecrets.org/news/category/issues-and-legislation/" rel="category tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Issues and Legislation</a> <a href="https://www.opensecrets.org/news/category/influence-lobbying/lobbying/" rel="category tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Lobbying</a> <a href="https://www.opensecrets.org/news/category/influence-lobbying/industries/pharmaceutical/" rel="category tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Pharmaceutical/Health products</a></div><div style="text-align: left;">
</div><div style="text-align: left;">Tags: <a href="https://www.opensecrets.org/news/tag/affordable-care-act/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Affordable Care Act</a>, <a href="https://www.opensecrets.org/news/tag/barack-obama/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Barack Obama</a>, <a href="https://www.opensecrets.org/news/tag/bernie-sanders/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Bernie Sanders</a>, <a href="https://www.opensecrets.org/news/tag/billy-tauzin/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Billy Tauzin</a>, <a href="https://www.opensecrets.org/news/tag/daraprim/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Daraprim</a>, <a href="https://www.opensecrets.org/news/tag/diana-zuckerman/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Diana Zuckerman</a>,<a href="https://www.opensecrets.org/news/tag/george-w-bush/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">George W Bush</a>, <a href="https://www.opensecrets.org/news/tag/hillary-clinton/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Hillary Clinton</a>, <a href="https://www.opensecrets.org/news/tag/john-castellani/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">John Castellani</a>, <a href="https://www.opensecrets.org/news/tag/kaiser-family-foundation/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Kaiser Family Foundation</a>, <a href="https://www.opensecrets.org/news/tag/lobbying/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">lobbying</a>, <a href="https://www.opensecrets.org/news/tag/marcia-angell/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Marcia Angell</a>, <a href="https://www.opensecrets.org/news/tag/martin-shkreli/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Martin Shkreli</a>, <a href="https://www.opensecrets.org/news/tag/medicare/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">medicare</a>, <a href="https://www.opensecrets.org/news/tag/medicare-modernization-act/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Medicare Modernization Act</a>, <a href="https://www.opensecrets.org/news/tag/medicare-part-d/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">medicare part d</a>, <a href="https://www.opensecrets.org/news/tag/obamacare/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">obamacare</a>, <a href="https://www.opensecrets.org/news/tag/pharmaceutical-research-and-manufacturers-of-america/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Pharmaceutical Research and Manufacturers of America</a>, <a href="https://www.opensecrets.org/news/tag/pharmaceuticalshealth-products-industry/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">pharmaceuticals/health products industry</a>, <a href="https://www.opensecrets.org/news/tag/phrma/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">phrma</a>, <a href="https://www.opensecrets.org/news/tag/sunlight-foundation/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Sunlight Foundation</a>, <a href="https://www.opensecrets.org/news/tag/turing-pharmaceuticals/" rel="tag" style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-line: none;">Turing Pharmaceuticals</a></div></footer>

<a href="https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/"> https://www.opensecrets.org/news/2015/10/pharmaceutical-industry-under-scrutiny-for-prices-has-history-of-big-political-wins/</a>==

Spencer, a staffer attached to the Republican cohort of the  Energy and Commerce Committee, was an obvious choice. Under previous chairman Billy Tauzin, he had been instrumental in organizing <a href="http://republicans.energycommerce.house.gov/107/hearings/07252002Hearing676/print.htm" sl-processed="1" style="border: 0px; font-style: inherit; margin: 0px; outline: 0px; padding: 0px; vertical-align: baseline;">an Oversight and Investigations subcommittee hearing on the use of climate models in the U.S. National Assessment </a>in 2002. That session heard from a “balanced” panel of five scientists that included climate science critics Patrick Michaels and Roger Pielke, Sr.  (Spencer has kept up his interest in climate science; he accepted a<a href="http://www.legistorm.com/trip/list/by/traveler/id/8305/name/Peter_Spencer.html" sl-processed="1" style="border: 0px; font-style: inherit; margin: 0px; outline: 0px; padding: 0px; vertical-align: baseline;">trip to the 2009 Heartland Institute </a><a href="http://www.legistorm.com/trip/list/by/traveler/id/8305/name/Peter_Spencer.html" sl-processed="1" style="border: 0px; font-style: inherit; margin: 0px; outline: 0px; padding: 0px; vertical-align: baseline;">International Conference on Climate Change</a> in New York, with Barton’s approval).

===

<div style="background-color: rgba(224, 224, 224, 0.2); text-align: left;">Tauzin says he and former House Majority Leader Dick Armey were the original architects of the tea party. In 1997, Tauzin writes, he and Armey staged a series of debates  held in 40 cities called "Scrap the Code," which called for a flat tax and a national retail sales tax. </div><div style="background-color: rgba(224, 224, 224, 0.2); text-align: left;">
</div>

<div style="text-align: left;">The tour kicked off in the Boston Harbor, where Tauzin said he tossed overboard a chest containing the then-1,100-page Tax Code (it’s now longer). During each of his stops, he called for a new American tea party, he said. Armey argued on behalf of a flat tax over the current income tax system.</div><div style="background-color: rgba(224, 224, 224, 0.2); text-align: left;">
</div>

<div style="background-color: rgba(224, 224, 224, 0.2); text-align: left;">
</div><div style="background-color: rgba(224, 224, 224, 0.2); text-align: left;">Read Latest Breaking News from Newsmax.com</div><div style="background-color: rgba(224, 224, 224, 0.2); text-align: left;">malware in survey?]</div>

==

this town: the alex rodriguez of lobby 180; 11.6m$ 2010 p 169

===

<div style="background-color: rgba(224, 224, 224, 0.2); text-align: left;">energy bill 2003 tauzin, delay domenici, ethanol, mod gop got anwr out in return for new power plants and hummer 100K tax break, protected delay biggest donor lyondell chem from mtbe suits and keep on mkt max p 113 "oinking mastodon"   heritage and cato! did not pass, big defeat b2, but redone next yr</div><div style="background-color: rgba(224, 224, 224, 0.2); text-align: left;"> </div>

===

rfk2:

ch 8

dascle held energy bill 18 mos till gop got both houses in 1/2003  Delay and

energy comm chair Billy Tauzin passed, but know it cd not pass, so bait

and switched: passed dem bill then rewrote it w/o dems 145, just energy lobby

;released the bill Sat night, 3 days to review 1200 pages 147 damage env and add

to debt (100B tax breaks McC: no lobbyist left behind"  for Hooters and Polluters.

Halib tax break to frack ; worst bill for envir in 25 yrs (back to newt Reg reform")

More for oil, more ghg. ethanol subsid peeled off demos, incl daschle and harkin;

DC and lobbists worked hard; even WSJ deplored pork for votes 149

House passed Domenici onmibus? bill [same as energy bill?], but sen filibuster.

WSJ "cornucopia of special interst payoffs" 151 some gop sununu held out, big debt

and MTBE outrage (delay, tauzin and barton)"Major Threat to Better Earnings' etc

shell jokes; used b/c lobby tho more $ than ethanol 155 cost to clean cd be $29-46

billion, co try to dodge .

===

<a href="http://www.sourcewatch.org/index.php?title=Billy_Tauzin">http://www.sourcewatch.org/index.php?title=Billy_Tauzin</a>

Former Republican Congressman Billy Tauzin commenced work as the head of the <a href="http://www.sourcewatch.org/index.php/Pharmaceutical_Research_and_Manufacturers_of_America" title="Pharmaceutical Research and Manufacturers of America" style="">Pharmaceutical Research and Manufacturers of America</a> (PhRMA) in early January 2005. Tauzin is also registered as a lobbyist for PhRMA. <a href="http://www.sourcewatch.org/index.php?title=Billy_Tauzin#cite_note-0">[1]</a>

Tauzin was criticised by Democrats early in 2004 when it was rumoured he was negotiating with the drug industry over a possible job. Tauzin had spent almost a full year shepherding the Medicare Prescription Drug Benefit Bill through Congress. The pharmaceutical industry will reap windfall profits from the Medicare drug bill.

Tauzin resigned as chairman of the House Energy and Commerce Committee, which has oversight of the drug industry, and did not re-contest his seat in the November 2004 eleection. In December 2004 PhRMA confirmed that Tauzin would head the organization. <a href="http://www.sourcewatch.org/index.php?title=Billy_Tauzin#cite_note-1">[2]</a>

USA Today reported in January 2005 that Tauzin's pay package is rumoured to be greater than $2 million a year. <a href="http://www.sourcewatch.org/index.php?title=Billy_Tauzin#cite_note-2">[3]</a>

<h2 style="background-color: rgba(224, 224, 224, 0.2); text-align: left;">Other SourceWatch resources</h2>

<li style="text-align: left;"><a href="http://www.sourcewatch.org/index.php/Government-industry_revolving_door" title="Government-industry revolving door">Government-industry revolving door</a></li>

</ul>

<h2 style="background-color: rgba(224, 224, 224, 0.2); text-align: left;">References</h2>

<li id="cite_note-0" style="text-align: left;"><a href="http://www.sourcewatch.org/index.php?title=Billy_Tauzin#cite_ref-0">↑</a> "<a rel="nofollow" class="external text" href="http://www.forbes.com/feeds/ap/2007/08/17/ap4031611.html">Drug Trade Group Spent $10.7M Lobbying</a>", Associated Press, August 17, 2007.</li>

<li id="cite_note-1" style="text-align: left;"><a href="http://www.sourcewatch.org/index.php?title=Billy_Tauzin#cite_ref-1">↑</a> Judy Sarasohn, "<a rel="nofollow" class="external text" href="http://www.washingtonpost.com/wp-dyn/articles/A3504-2004Dec15.html">Tauzin to Head Drug Trade Group</a>", Washington Post, December 16, 2004.</li>

<li id="cite_note-2" style="text-align: left;"><a href="http://www.sourcewatch.org/index.php?title=Billy_Tauzin#cite_ref-2">↑</a> William M. Welch, "<a rel="nofollow" class="external text" href="http://www.usatoday.com/money/industries/health/drugs/2004-12-15-drugs-usat_x.htm">Tauzin switches sides from drug industry overseer to lobbyist</a>", USA TODAY, December 15, 2004.</li>

</ol>

<h2 style="background-color: rgba(224, 224, 224, 0.2); text-align: left;">External links</h2>

<li style="text-align: left;">Frank Ahrens, "<a rel="nofollow" class="external text" href="http://www.washingtonpost.com/wp-dyn/articles/A42531-2004Jan23.html?nav=hptoc_p">24 Tauzin Expected To Leave House For Trade Group. Lawmaker Declined Hollywood Job</a>", Washington Post, January 2004: "Rep. W.J. Billy Tauzin (R-La.) is close to a decision to leave Congress to head the pharmaceutical industry's trade association (Pharmaceutical Research and Manufacturers of America (PhRMA), the trade group that represents drug giants such as Pfizer Inc. and Merck & Co.) after turning down an offer from Hollywood to succeed Jack Valenti as the movie industry's top lobbyist, sources in Washington and California said yesterday."</li>

<li style="text-align: left;">Jeanne Lenzer, "<a rel="nofollow" class="external text" href="http://bmj.bmjjournals.com/cgi/content/full/330/7482/60-b?etoc">Ties between regulators and business are attacked after politician takes top job in industry</a>", British Medical Journal, Volume 330, No 7842, January 8, 2005.</li>

</ul>

</div>

<div id="mw-normal-catlinks" class="mw-normal-catlinks"><div style="text-align: left;"><a href="http://www.sourcewatch.org/index.php/Special:Categories" title="Special:Categories">Categories</a>:</div><ul>

<li style="text-align: left;"><a href="http://www.sourcewatch.org/index.php/Category:Lobbyists" title="Category:Lobbyists">Lobbyists</a></li>

<li style="text-align: left;"><a href="http://www.sourcewatch.org/index.php/Category:United_States" title="Category:United States">United States</a></li>

<li style="text-align: left;"><a href="http://www.sourcewatch.org/index.php/Category:Pharmaceutical_industry" title="Category:Pharmaceutical industry">Pharmaceutical industry</a></li>

</ul>

</div>

==

Buying Legislators Can Be Expensive

Today’s system of buying legislators is effective but somewhat expensive. This system involves investing in the purchase of numerous legislators through campaign contributions and/or offers of lucrative post-government-service jobs to legislators and staffers. This system generates tremendous returns—a few million spread around can yield billions.

The poster-child of this old system, of course, remains Representative Billy Tauzin (R-LA), who was chairman of the committee in the House that regulates the pharmaceutical industry. Tauzin ushered through the Medicare prescription drug program that was so beneficial to the pharmaceutical industry. He retired very soon after it passed <a target="blank" href="http://www.usatoday.com/money/industries/health/drugs/2004-12-15-drugs-usat_x.htm">to take a job as head of the pharmaceutical lobbying group</a>, the Pharmaceutical Research and Manufacturers of America. According to <a target="blank" href="http://www.bloomberg.com/news/2011-11-29/tauzin-s-11-6-million-made-him-highest-paid-health-law-lobbyist.html">Bloomberg News</a> Tauzin received lobbying income of $11.6 million in 2010.

===

<h2 class="headline" style="background-color: rgba(224, 224, 224, 0.2); text-align: left;"><a href="http://boingboing.net/2012/03/17/average-congresscritter-gets-1.html" rel="bookmark">Average Congresscritter gets 1,452% raises when they turn corporate lobbyist</a></h2>

By <a href="http://boingboing.net/author/cory_doctorow_1" title="Posts by Cory Doctorow" rel="author">Cory Doctorow</a> at 5:55 pm Saturday, Mar 17

Republic Report has released figures documenting the fact that the average member of Congress gets a 1,452% salary hike when she or he leaves office and becomes a corporate lobbyist. They point out that politicians are allowed to negotiate these raises while they are in office, and don't have to disclose this fact when they're working on legislation that will benefit their future employers. One of the poster children for this is former Senator Judd Gregg (R-NH) who fought against financial reforms to the derivatives market, then joined the board of a derivatives-trading company and was given an advisory role at Goldman Sachs.

Our research effort uncovered the partial salaries of twelve lawmakers-turned-lobbyists. Republic Report’s investigation found that lawmakers increased their salary by 1452% on average from the last year they were in office to the latest publicly available disclosure:

Former Congressman Billy Tauzin (R-LA) made $19,359,927 as a lobbyist for pharmaceutical companies between 2006 and 2010. Tauzin retired from Congress in 2005, shortly after leading the passage of President Bush’s prescription drug expansion. He was recruited to lead PhRMA, a lobbying association for Pfizer, Bayer, and other top drug companies. During the health reform debate, the former congressman helped his association block a proposal to allow Medicare to negotiate for drug prices, a major concession that extended the policies enacted in Tauzin’s original Medicare drug-purchasing scheme. Tauzin left PhRMA in late 2010. He was paid over $11 million in his last year at the trade group. Comparing Tauzin’s salary during his last year as congressman and his last year as head of PhRMA, his salary went up 7110%.

Former Congressman Cal Dooley (D-CA) has made at least $4,719,093 as a lobbyist for food manufacturers and the chemical industry from 2005 to 2009. Republic Report analyzed disclosures from the Grocery Manufacturers Association (GMA), an industry lobby — for companies like Kellogg — where Dooley worked following his retirement from Congress. We also added in Dooley’s salary from the American Chemistry Council, where Dooley now works as the president. The Chemistry Council represents Dow Chemical, DuPont, and other chemical interests. Dooley’s salary jumped 1357% between his last year in the House and his last reported salary for the Chemistry Council in 2009.

Former Senator Chris Dodd (D-CT) makes approximately $1.5 million a year as the chief lobbyist for the movie industry. Dodd, who retired from the Senate after 2010, was hired by the Motion Picture Association of America, the lobbying association that represents major studios like Warner Bros. and Universal Studios. Although the MPAA would not confirm with Republic Report Dodd’s exact salary, media accounts point to $1.5 million, a slightly higher figure than the previous MPAA head, former Secretary of Agriculture Dan Glickman. Dodd received about a 762% raise after moving from public office to lobbying.

</blockquote>

<a href="http://www.republicreport.org/2012/make-it-rain-revolving-door/">ANALYSIS: When a Congressman Becomes a Lobbyist, He Gets a 1,452% Raise (on Average)</a>

-----

<table cellspacing="1" cellpadding="1" border="0" style="background-color: rgb(255, 255, 255);"><tbody><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">ADVANCED COMPUTER AND COMMUNICATIONS LLC</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-51</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/68b053da-4bdd-5982-a12b-7d52e6dc06b0.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">ARNALL GOLDEN GREGORY LLP</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-176</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/adcb0025-58da-5ea0-b231-2b005f91a530.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">ASSOCIATION OF AIR MEDICAL SERVICES</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-152</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/c42a0e30-16d8-5ab9-8339-884fd0e5e957.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">BITUMINOUS COAL OPERATORS ASSOCIATION, INC.</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-90</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/e38988d3-6169-51cc-b8ef-a4e5c7126c92.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">CAPTURERX</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-75</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/4513f723-e079-556a-b52c-8532ae42ac58.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">COMMITTEE TO SAVE INDEPENDENT HME SUPPLIERS, LLC</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-101</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/ce540eca-d213-5c5b-bfb0-50916c002d8a.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">DBA INTERNATIONAL</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-87</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/66de022b-bd9e-5e97-8514-cafff05b30d0.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">EXOTIC WILDLIFE ASSOCIATION</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-137</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/da6a2208-10ed-59b8-ac95-0a8fbb1fc24c.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">GC BARNES GROUP, LLC</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-188</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/f1010465-8f6a-5e47-91d0-a3a62f78dc04.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">GSM INTEGRATED CONTROLS USA</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-63</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/d201960a-9030-5d5b-9bcc-74fc7ed92720.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">GUARDIAN ANALYTICS</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-24</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/117d7c9a-df42-5fb0-9626-42bed7f041af.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">INDUSTRIAL SAFETY TRAINING COUNCIL</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-113</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/b72b5740-af8f-58e0-ad0c-77f4d6adc9e0.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">INVACARE CORPORATION</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-140</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/6ef72532-bcf7-5c1a-b747-cb51e6199329.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">JAMES R. WOODHILL</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-36</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/8df6d0b9-e8c9-54a0-8505-6fa951998049.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">RESILIENT NETWORK SYSTEMS, INC.</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-12</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/a4c1aa91-c61f-51d0-81ee-c92ecdcb07d5.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">SCAN HEALTH PLAN</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-125</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/53a901aa-c046-501d-ab0a-3f8ce73ad282.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">ST. CHARLES PARISH</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-48</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/54e581cd-de19-54e0-88a2-dbebe6ac63eb.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN CONSULTANTS, LLC</td><td valign="top" style=" font-size: 12px;">VGM GROUP, INC.</td><td valign="top" nowrap="true" style=" font-size: 12px;">400671007-164</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/88848c9b-1358-5ad5-b6a0-a92287d9cfbd.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN STRATEGIC NETWORKS</td><td valign="top" style=" font-size: 12px;">EMD SERONO</td><td valign="top" nowrap="true" style=" font-size: 12px;">400786367-24</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/e88b7f73-1645-5677-a5b4-b446739b960b.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN STRATEGIC NETWORKS</td><td valign="top" style=" font-size: 12px;">ENDO PHARMACEUTICALS, INC.</td><td valign="top" nowrap="true" style=" font-size: 12px;">400786367-36</td></tr><tr><td colspan="3" style=" font-size: 12px;"><img src="/9cf5f3e8-58e6-5a2d-8bc5-d17bd796a2e3.gif"/></td></tr><tr><td valign="top" style=" font-size: 12px;">TAUZIN STRATEGIC NETWORKS</td><td valign="top" style=" font-size: 12px;">PARTNERSHIP FOR QUALITY HOME HEALTHCARE</td><td valign="top" nowrap="true" style=" font-size: 12px;">400786367-12</td></tr></tbody></table>

</div>

Tauzin, Billy Rep

Attachments